NDC 38739-200

SYMJEPI

Epinephrine

SYMJEPI is a Intramuscular; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Adamis Pharmaceuticals Corporation. The primary component is Epinephrine.

Product ID38739-200_aea6fa4f-6916-4e6c-96f8-d2c47b332314
NDC38739-200
Product TypeHuman Prescription Drug
Proprietary NameSYMJEPI
Generic NameEpinephrine
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR; SUBCUTANEOUS
Marketing Start Date2017-11-15
Marketing CategoryNDA / NDA
Application NumberNDA207534
Labeler NameAdamis Pharmaceuticals Corporation
Substance NameEPINEPHRINE
Active Ingredient Strength0 mg/.3mL
Pharm ClassesAdrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 38739-200-06

6 CARTON in 1 CARTON (38739-200-06) > 1 SYRINGE in 1 CARTON (38739-200-01) > .3 mL in 1 SYRINGE
Marketing Start Date2017-11-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 38739-200-02 [38739020002]

SYMJEPI INJECTION
Marketing CategoryNDA
Application NumberNDA207534
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-15

NDC 38739-200-12 [38739020012]

SYMJEPI INJECTION
Marketing CategoryNDA
Application NumberNDA207534
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-15

NDC 38739-200-01 [38739020001]

SYMJEPI INJECTION
Marketing CategoryNDA
Application NumberNDA207534
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-15

NDC 38739-200-06 [38739020006]

SYMJEPI INJECTION
Marketing CategoryNDA
Application NumberNDA207534
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-11-15

Drug Details

Active Ingredients

IngredientStrength
EPINEPHRINE.3 mg/.3mL

OpenFDA Data

SPL SET ID:4b414a33-7371-4801-ae16-59db8c7b1aab
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1989117
  • 1989112

    • Pharmacological Class

    • Adrenergic alpha-Agonists [MoA]
    • Adrenergic beta-Agonists [MoA]
    • alpha-Adrenergic Agonist [EPC]
    • beta-Adrenergic Agonist [EPC]
    • Catecholamine [EPC]
    • Catecholamines [CS]
    • Adrenergic alpha-Agonists [MoA]
    • Adrenergic beta-Agonists [MoA]
    • alpha-Adrenergic Agonist [EPC]
    • beta-Adrenergic Agonist [EPC]
    • Catecholamine [EPC]
    • Catecholamines [CS]

    NDC Crossover Matching brand name "SYMJEPI" or generic name "Epinephrine"

    NDCBrand NameGeneric Name
    0781-3442SYMJEPIEpinephrine
    0781-3448SYMJEPIEpinephrine
    38739-200SYMJEPISYMJEPI
    78670-131SymjepiSymjepi
    78670-130SymjepiSymjepi
    0220-0076AdrenalinumEPINEPHRINE
    0220-0078AdrenalinumEPINEPHRINE
    0093-5985EpinephrineEpinephrine
    0093-5986EpinephrineEpinephrine
    0115-1694epinephrineepinephrine
    0115-1695epinephrineepinephrine
    0404-9856EpinephrineEpinephrine
    0404-9857EPINEPHRINEEPINEPHRINE
    0409-4921EpinephrineEPINEPHRINE
    0409-4933EPINEPHRINEepinephrine
    0409-7241EPINEPHRINEepinephrine
    0517-1130EpinephrineEpinephrine
    0517-1171epinephrineepinephrine

    Trademark Results [SYMJEPI]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    SYMJEPI
    SYMJEPI
    88162331 5853281 Live/Registered
    Adamis Pharmaceuticals Corporation
    2018-10-19
    SYMJEPI
    SYMJEPI
    86582435 not registered Dead/Abandoned
    Adamis Pharmaceuticals Corporation
    2015-03-31
    SYMJEPI
    SYMJEPI
    86582421 not registered Dead/Abandoned
    Adamis Pharmaceuticals Corporation
    2015-03-31
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.